Literature DB >> 15006474

Presynaptic stimulation and development of locomotor sensitization to the dopamine agonist quinpirole.

Anna Lomanowska1, Stephanie Gormley, Henry Szechtman.   

Abstract

To assess whether locomotor sensitization induced by repeated injections of the dopamine agonist quinpirole reflects tolerance of the drug's presynaptic depressive effects on locomotion, independent groups of rats were treated chronically (every 3 daysx10) with either a presynaptic dose of quinpirole (0.025 mg/kg; n=27), a postsynaptic dose (0.5 mg/kg; n=27), or saline (n=26). Following chronic treatment, a full dose-response profile was determined to assess the presence of sensitization. Results indicated that treatment with the postsynaptic, but not the presynaptic, dose of quinpirole induced locomotor sensitization. Moreover, chronic treatment with low-dose quinpirole did not yield tolerance of the drug's depressive effects. It is suggested that presynaptic dopamine receptors may require extensive spatial and/or temporal summation to become tolerant.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006474     DOI: 10.1016/j.pbb.2003.12.018

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  3 in total

1.  Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors.

Authors:  Valerie Voon; Mathias Pessiglione; Christina Brezing; Cecile Gallea; Hubert H Fernandez; Raymond J Dolan; Mark Hallett
Journal:  Neuron       Date:  2010-01-14       Impact factor: 17.173

2.  Influence of body weight and type of chow on the sensitivity of rats to the behavioral effects of the direct-acting dopamine-receptor agonist quinpirole.

Authors:  Michelle G Baladi; Amy H Newman; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2011-05-05       Impact factor: 4.530

3.  Putting desire on a budget: dopamine and energy expenditure, reconciling reward and resources.

Authors:  Jeff A Beeler; Cristianne R M Frazier; Xiaoxi Zhuang
Journal:  Front Integr Neurosci       Date:  2012-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.